首页> 美国卫生研究院文献>Clinical Orthopaedics and Related Research >Allograft Reconstruction After Sarcoma Resection in Children Younger Than 10 Years Old
【2h】

Allograft Reconstruction After Sarcoma Resection in Children Younger Than 10 Years Old

机译:10岁以下儿童肉瘤切除后的同种异体移植重建

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Preservation of limb function in pediatric oncology patients is challenging with the ongoing growth of limbs contralateral to reconstructed limbs. We analyzed 22 patients younger than 10 years old who received an allograft after resection of a bone sarcoma with a minimum followup of 2 years (mean, 4 years; range, 2–14 years). The mean age was 7 years (range, 2–10 years). There were 16 boys and six girls with 17 osteosarcomas and five Ewing’s sarcomas. Thirteen reconstructions were performed with an intercalary allograft and nine with an osteoarticular allograft. Physes were uninvolved in five patients and one physis in 17. We documented outcomes using the Musculoskeletal Tumor Society functional and the International Society of Limb Salvage radiographic scoring systems. At last followup, three of the 22 patients died of their tumor, one was alive but with an amputation, and 18 retained their limbs. These 18 patients had an average functional score of 27 points and a mean radiographic score of 94%. Eight complications required a second surgery; in four, the allograft was removed (one infection, one local recurrence, two fractures) and in four, the allograft was preserved (two local recurrences, one fracture, one nonunion). We consider biologic reconstruction with allografts after sarcoma resection an appropriate reconstructive procedure in young children.>Level of Evidence: Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.
机译:随着重建肢体对侧肢体的持续生长,在小儿肿瘤科患者中保持肢体功能具有挑战性。我们分析了22例年龄小于10岁的骨肉瘤切除术后接受同种异体移植的患者,至少随访2年(平均4年;范围2-14岁)。平均年龄为7岁(范围为2-10岁)。有16个男孩和6个女孩患有17个骨肉瘤和5个Ewing肉瘤。 cal间同种异体移植进行了十三次重建,同种异体骨进行了九次重建。 5名患者未参与任何身体检查,17名患者未参与任何身体检查。我们使用肌肉骨骼肿瘤学会功能和国际肢体挽救协会射线照相评分系统记录了结局。在最后一次随访中,22例患者中有3例死于肿瘤,1例还活着但被截肢,18例保留了四肢。这18例患者的平均功能评分为27分,平均影像学评分为94%。八种并发症需要第二次手术。在四例中,去除了同种异体移植物(一次感染,一例局部复发,两例骨折),四例中,保留了同种异体移植物(两次局部复发,一例骨折,一例不愈合)。我们认为肉瘤切除后同种异体移植的生物重建是适合幼儿的适当重建程序。>证据水平: IV级,治疗研究。有关证据水平的完整说明,请参见《作者指南》。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号